HF
FENC icon

HRT Financial’s Fennec Pharmaceuticals FENC Stock Holding History

HRT Financial’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,395
Closed -$102K – 3089
2025
Q2 		$102K Buy
+12,395
New +$84.8K ﹤0.01% 2204
2023
Q2 		– Sell
-54,635
Closed -$454K – 2705
2023
Q1 		$454K Buy
+54,635
New +$507K 0.01% 1448
2021
Q4 		– Sell
-55,935
Closed -$526K – 3453
2021
Q3 		$526K Sell
55,935
-6,055
-10% -$45.4K ﹤0.01% 1920
2021
Q2 		$451K Buy
+61,990
New +$414K ﹤0.01% 1870

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's FENC Position: Q3 2025 in Review

HRT Financial sold out of Fennec Pharmaceuticals (FENC) in Q3 2025, closing a stake of 12,395 shares — an estimated $102K sold.

HRT Financial first reported a position in FENC in Q2 2021 and held it in 4 quarters. The position peaked at $526K in Q3 2021. 84 funds tracked by Wall St. Rank hold FENC as of Q3 2025.

  • HRT Financial reported no remaining Fennec Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 12,395 Fennec Pharmaceuticals shares in Q3 2025, an estimated $102K.
  • HRT Financial first reported a position in Fennec Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • HRT Financial's Fennec Pharmaceuticals position peaked at $526K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.